Actinogen Medical Limited (ASX:ACW)
Australia · Delayed Price · Currency is AUD 0.0580
-0.0010 (-1.69%)
Sep 10, 2026, 4:10 PM AEST
Actinogen Medical Market Cap
Actinogen Medical has a market cap or net worth of 215.72 million as of September 10, 2026. Its market cap has increased by 142.62% in one year.
Market Cap
215.72M
Enterprise Value
203.77M
Revenue
12.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since October 16, 2007, Actinogen Medical's market cap has increased from 12.97M to 215.72M, an increase of 1,562.94%. That is a compound annual growth rate of 16.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 215.72M | 10.97% |
| Dec 31, 2025 | 194.40M | 148.21% |
| Dec 31, 2024 | 78.32M | 54.29% |
| Dec 29, 2023 | 50.76M | -71.90% |
| Dec 30, 2022 | 180.63M | -36.39% |
| Dec 31, 2021 | 283.98M | 832.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 411.74M |
| Clinuvel Pharmaceuticals | 406.95M |
| Tetratherix | 387.69M |
| Starpharma Holdings | 386.25M |
| BLS Pharmaceuticals | 260.24M |
| Orthocell | 198.80M |
| Nyrada | 176.67M |
| Paradigm Biopharmaceuticals | 164.78M |